Mechanistic target of rapamycin (mTOR) inhibitors may be successful tx of sarcoidosis. Abs 0136 is an interesting study yielding more questions than answers. #ACR22 @RheumNow https://t.co/0Q260CGw3r https://t.co/LepPOrq7Gv
Links:
Sarcoidosis Incidence After mTOR Inhibitor Treatment - ACR Meeting Abstracts
http://ow.ly/cGbn50LtLIt
12-11-2022
